Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06815354 · ClinicalTrials.gov registry record · NA

Comprehensive Assessment of Cancer Theranostic Response

A NA study of Prostate Cancer, sponsored by AIQ Solutions.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
2
Study locations

NCT06815354: Recruiting NA study of Prostate Cancer, sponsored by AIQ Solutions.

NCT06815354 is a NA study of Prostate Cancer that is actively recruiting participants, run by AIQ Solutions. The registered enrollment target is 32 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06815354, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by AIQ Solutions.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
2
Study locations

Study Summary

The intent of this study is to evaluate actionable outputs from TRAQinform Theranostics in a prospective, multi-center, non-interventional clinical study. The primary objective is to investigate intent-to-change treatment decisions after the addition of TRAQinform Theranostics. The exploratory objective is to investigate if treatment efficacy and treatment-related toxicity could be detected by TRAQinform Theranostics following PSMA PET/CT at week 12.

Conditions Studied

Prostate Cancer

Interventions

  • DEVICE TRAQinform Theranostics

Study Locations (2)

New York

  • Weill Medical College of Cornell - New York

Texas

  • M.D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2024-12-02
Est. Completion 2026-05-29
Phase NA

Sponsor

AIQ Solutions

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06815354

The ClinicalTrials.gov registry entry for NCT06815354 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (95% lower). The listed sponsor is AIQ Solutions, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which TRAQinform Theranostics is the first listed.

NCT06815354 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Texas.

Frequently Asked Questions

What is clinical trial NCT06815354 about?

NCT06815354 is a clinical study titled "Comprehensive Assessment of Cancer Theranostic Response". The intent of this study is to evaluate actionable outputs from TRAQinform Theranostics in a prospective, multi-center, non-interventional clinical study. The primary objective is to investigate intent-to-change treatment decisions after the addition of TRAQinform Theranostics. The exploratory objec...

What is the current status of trial NCT06815354?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2024-12-02. Estimated completion is 2026-05-29.

What conditions does trial NCT06815354 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06815354?

The interventions under investigation include: TRAQinform Theranostics (DEVICE).

Who is sponsoring clinical trial NCT06815354?

This trial is sponsored by AIQ Solutions, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06815354 being conducted?

This trial has 2 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.